“This money will give us enough to do everything we need, including product development, paying staff, product validation and manufacturing partnerships,” Kopparthi exclusively told me Monday. “We will apply for FDA clearance in May and ideally, will have the clearance in six to eight months.”
###
NeoLight is a medical device company that develops empathy driven, best-in-class technologies for treating preventable conditions in the newborn care market. Empathy driven solutions are a framework that has the doctor-nurse-mother-infant ecosystem at the center. It fosters the emotional connection that happens, thereby providing not just treatment but also providing care. Driving neonatal care beyond the traditional hospital setting, NeoLight is also creating a robust home market to treat neonatal conditions in the home. To learn more, visit www.theneolight.com and follow us on Twitter and LinkedIn.
